Streamline Your Life Sciences Pipeline Deals with airSlate SignNow
airSlate SignNow regularly wins awards for ease of use and setup
See airSlate SignNow eSignatures in action
Our user reviews speak for themselves
Why choose airSlate SignNow
-
Free 7-day trial. Choose the plan you need and try it risk-free.
-
Honest pricing for full-featured plans. airSlate SignNow offers subscription plans with no overages or hidden fees at renewal.
-
Enterprise-grade security. airSlate SignNow helps you comply with global security standards.
Pipeline Deals for Life Sciences
Pipeline deals for Life Sciences
With airSlate SignNow, you can increase efficiency, reduce paper usage, and speed up the signing process in your Life Sciences organization. Take advantage of features like document templates, fillable fields, and secure eSignature capabilities to streamline your workflows and close deals faster.
Experience the benefits of airSlate SignNow for Life Sciences today and optimize your document management processes!
airSlate SignNow features that users love
Get legally-binding signatures now!
FAQs online signature
-
What is the life sciences M&A trend in 2024?
In 2024, we expect M&A will more closely resemble prior years with a total deal value in the $225 billion to $275 billion range across all subsectors of the life sciences industry.
-
Who are the big mergers in pharma?
Largest M&A pharmaceutical deals ever as of 2024 The most recent big deals were the acquisitions of Allergan by AbbVie and of Celgene by Bristol-Myers Squibb, both in 2019. In 2023, the largest biopharma M&A deal was the acquisition of Seagen by Pfizer, valued at around 43 billion U.S. dollars.
-
What are the most recent M&A deals for healthcare?
Recent healthcare M&A deals: recent notable deals include Novo Holdings' acquisition of Catalent, CVS Health's acquisition of Oak Street Health, and Optum's acquisition of Amedisys.
-
What is the M&A forecast for 2024?
Global: In the first half of 2024, while the value of M&A deals rose by 5% compared to the first half of 2023, overall transaction volume fell by 30%, continuing a downward trend that started in 2022. In the first half of 2024, deal volumes were just over 21,000 and deal values reached $1.3tn.
-
What is the forecast for mergers and acquisitions?
Mergers and Acquisitions - Worldwide Consequently, the total transaction value in the market is expected to stand at US$2.69tn by 2024. Furthermore, the average transaction value in the Mergers and Acquisitions market market is predicted to amount to US$181.00m in 2024.
-
What is the EY M&A forecast?
Based on the Macroeconomics team's US economic outlook, the EY Deal Barometer estimates corporate M&A deal volume (for deals over $100 million) will gradually pick up, rising 20% in 2024, following a 17% contraction in 2023. (See Figure 1 below.)
-
What is the M&A report for Q1 2024?
M&A activity kicked off 2024 with the strongest start in two years with over $549B in global deal volumes—a 28% increase compared to Q1'23. This pickup was driven by a burst of megadeals (deals larger than $10B).
Trusted e-signature solution — what our customers are saying
How to create outlook signature
so if you have the opportunity to acquire an asset that's strategically aligned and it's 10 cents on the dollar versus one that's strategically aligned and is uh 110 cents on the dollar bargain hunting can happen does happen will happen but you have to look at the longer term picture what are the integration costs going to look like how long is this going to take when will it have an impact and shareholder value whether you're a public company or a small private is really what you're striving to achieve so the strategy that you lay out should be focused on deriving increased shareholder value over time and those transactions that you consummate should all build towards that and the idea is that you put first and foremost those deals that have the greatest opportunity the greatest propensity to add shareholder value over time
Show more